“…The HPV E7 protein can induce cellular proliferation through several pathways by disrupting the activity of cyclin-dependent kinase (CDK) inhibitors p21 and p27, activation of CDKs and destabilization of the Rb tumor suppressor protein [for review see [20][21][22][23][24]. Rb family members (pRb, p107, p130) are instrumental in the control of cell cycle progression largely through regulation of the E2F family of transcription factors [23,25]. Thus, binding of E7 to hypophosphorylated Rb results in the release of E2F factors that are necessary for transcription of genes involved in proliferation and cell cycle progression.…”
“…The HPV E7 protein can induce cellular proliferation through several pathways by disrupting the activity of cyclin-dependent kinase (CDK) inhibitors p21 and p27, activation of CDKs and destabilization of the Rb tumor suppressor protein [for review see [20][21][22][23][24]. Rb family members (pRb, p107, p130) are instrumental in the control of cell cycle progression largely through regulation of the E2F family of transcription factors [23,25]. Thus, binding of E7 to hypophosphorylated Rb results in the release of E2F factors that are necessary for transcription of genes involved in proliferation and cell cycle progression.…”
“…At present, more than 150 different HPV genotypes have been isolated and grouped roughly into mucosal (a) or skin (b) genotypes, according to their preferred target tissue (De Villiers et al, 2004;Munger et al, 2004). Productive HPV infection has long been known to cause benign squamous hyperplasias, also known as warts.…”
“…Although human papillomavirus (HPV) vaccines are available, cervical cancer still causes a considerable amount of death because of the limited application of the vaccine. Persistent infection with high‐risk HPV is the main aetiological factor in cervical carcinogenesis 2, 3, 4. However, HPV infection alone does not sufficiently explain the occurrence of cervical cancer because HPV oncogenes E6 and E7 can immortalize but do not transform human epithelial cells 5, 6.…”
Cervical cancer continues to be among the most frequent gynaecologic cancers worldwide. The phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) pathway is constitutively activated in cervical cancer. Inositol polyphosphate 4‐phosphatase type II (INPP4B) is a phosphoinositide phosphatase and considered a negative regulatory factor of the PI3K/AKT pathway. INPP4B has diverse roles in various tumours, but its role in cervical cancer is largely unknown. In this study, we investigated the role of INPP4B in cervical cancer. Overexpression of INPP4B in HeLa, SiHa and C33a cells inhibited cell proliferation, metastasis and invasiveness in CCK‐8, colony formation, anchorage‐independent growth in soft agar and Transwell assay. INPP4B reduced the expression of some essential proteins in the PI3K/AKT/SGK3 pathway including p‐AKT, p‐SGK3, p‐mTOR, phospho‐p70S6K and PDK1. In addition, overexpression of INPP4B decreased xenograft tumour growth in nude mice. Loss of INPP4B protein expression was found in more than 60% of human cervical carcinoma samples. In conclusion, INPP4B impedes the proliferation and invasiveness of cervical cancer cells by inhibiting the activation of two downstream molecules of the PI3K pathway, AKT and SGK3. INPP4B acts as a tumour suppressor in cervical cancer cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.